| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/24/2011 | US20110071196 Compounds Which Selectively Modulate The CB2 Receptor |
| 03/24/2011 | US20110071195 Novel alkene oxindole derivatives |
| 03/24/2011 | US20110071194 Chemical Compounds 572 |
| 03/24/2011 | US20110071193 Spot-on pesticide composition |
| 03/24/2011 | US20110071192 Therapeutic Agents Useful for Treating Pain |
| 03/24/2011 | US20110071190 Biphenyl compounds useful as muscarinic receptor antagonists |
| 03/24/2011 | US20110071189 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof |
| 03/24/2011 | US20110071188 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof |
| 03/24/2011 | US20110071187 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof |
| 03/24/2011 | US20110071186 Organic compounds |
| 03/24/2011 | US20110071185 Manufacture of tablet in a die utilizing powder blend containing water-containing material |
| 03/24/2011 | US20110071184 Manufacture of tablet in a die utilizing radiofrequency energy and meltable binder |
| 03/24/2011 | US20110071183 Manufacture of lozenge product with radiofrequency |
| 03/24/2011 | US20110071182 Inhibitors of AKT Activity |
| 03/24/2011 | US20110071181 Effervescent oral opiate dosage forms and methods of administering opiates |
| 03/24/2011 | US20110071180 Sub-type selective amides of diazabicycloalkanes |
| 03/24/2011 | US20110071179 Macrocyclic inhibitors of jak |
| 03/24/2011 | US20110071178 Methods and Compounds for Modulating Cannabinoid Activity |
| 03/24/2011 | US20110071176 Pharmaceutical composition comprising omega-3 fatty acid and hydroxy-derivative of a statin and methods of using same |
| 03/24/2011 | US20110071175 Indoles and Their Therapeutic Use |
| 03/24/2011 | US20110071174 Substituted quinazolines |
| 03/24/2011 | US20110071173 Imidazoquinazoline derivatives as anagrelide analogues for the treatment of myeloprolific diseases and thrombotic diseases |
| 03/24/2011 | US20110071172 Substituted quinazolines as blood platelet lowering agents |
| 03/24/2011 | US20110071171 2h- pyrimido [2, 1-b] quinazolin-2-one derivatives and their use as platelet anti-aggregative agents |
| 03/24/2011 | US20110071170 Tricyclic pyrazolopyrimidine derivatives |
| 03/24/2011 | US20110071169 Preparation of polymorphic form of lapatinib ditosylate |
| 03/24/2011 | US20110071168 Nitric oxide donors for inducing neurogenesis |
| 03/24/2011 | US20110071167 Method of treatment of age-related macular degeneration (amd) |
| 03/24/2011 | US20110071166 Medicine consisting of concomitant use or combination of dpp-iv inhibitor and other diabetic medicine |
| 03/24/2011 | US20110071165 Aza- and polyazanthranyl amides and their use as medicaments |
| 03/24/2011 | US20110071164 Erg channel openers for the treatment of cardiac arrhythmias |
| 03/24/2011 | US20110071163 Use of an opioid receptor antagonist for the treatment or prevention of gastrointestinal tract disorders |
| 03/24/2011 | US20110071162 Triazolopyridine carboxamide derivatives and triazolopyrimidine carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 03/24/2011 | US20110071161 Triazolopyridine carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 03/24/2011 | US20110071160 1,3-DIHYDRO-2H-PYRROLO[3,2-b]PYRIDIN-2-ONE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USES THEREOF |
| 03/24/2011 | US20110071159 6- (4-cyclopropylpiperazin-1-yl) -2 ' -methyl- [3, 4 ' ] -bipyridine and its use as a medicament |
| 03/24/2011 | US20110071158 New compounds |
| 03/24/2011 | US20110071157 Role of N-2-Hydroxy-Ethyl-Piperazine-N'-2-Ethane Sulfonic Acid (HEPES) in Pain Control and Reversal of Demyelinization Injury |
| 03/24/2011 | US20110071156 Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them |
| 03/24/2011 | US20110071155 Tricyclic Nitrogen Containing Compounds And Their Use As Antibacterials |
| 03/24/2011 | US20110071154 Pyrrolidin-3-ylmethyl-amine as orexin antagonists |
| 03/24/2011 | US20110071153 Dihydropyrazole derivatives as tyrosine kinase modulators for the treatment of tumors |
| 03/24/2011 | US20110071152 5-membered heterocycle-based p38 kinase inhibitors |
| 03/24/2011 | US20110071151 Abt-263 crystalline forms |
| 03/24/2011 | US20110071150 Indole derivatives as crac modulators |
| 03/24/2011 | US20110071149 Selective kinase inhibitors |
| 03/24/2011 | US20110071148 Compounds as the estrogen related receptors modulators and the uses thereof |
| 03/24/2011 | US20110071147 4-amino-thieno[3,2-c]pyridine-7-carboxylic acid amides |
| 03/24/2011 | US20110071146 17BetaHSD Type 5 Inhibitor |
| 03/24/2011 | US20110071145 Raf Modulators And Methods Of Use |
| 03/24/2011 | US20110071144 Quinazoline derivatives and pharmaceutical compositions containing them |
| 03/24/2011 | US20110071143 Fused triazole amines as p2x7 modulators |
| 03/24/2011 | US20110071142 Identification and use of small molecules to modulate transcription factor function and to treat transcription factor associated diseases |
| 03/24/2011 | US20110071141 Pesticidial Condensed-Ring Aryl Compounds |
| 03/24/2011 | US20110071140 Therapeutic pyrazoloquinoline urea derivatives |
| 03/24/2011 | US20110071139 Cycloalkyl Lactame Derivatives As Inhibitors Of 11-Beta-Hydroxysteroid Dehydrogenase 1 |
| 03/24/2011 | US20110071138 Pharmaceutical composition for the treatment of premature ejaculation |
| 03/24/2011 | US20110071137 Process for preparing sustained release tablets |
| 03/24/2011 | US20110071136 Novel tricyclic protein kinase modulators |
| 03/24/2011 | US20110071135 Method and composition for treating alzheimer-type dementia |
| 03/24/2011 | US20110071134 2-(amino-substituted)-4-aryl pyrimidines and related compounds useful for treating inflammatory diseases |
| 03/24/2011 | US20110071133 Bicyclic aryl and bicyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 03/24/2011 | US20110071132 Substituted oxindole derivatives, drugs containing said derivatives and the use thereof |
| 03/24/2011 | US20110071131 Substituted Spirocyclic Piperidine Derivatives as Histamine-3 (H3) Receptor Ligands |
| 03/24/2011 | US20110071130 2-aminobenzimidazoles for treating neurodegenerative diseases |
| 03/24/2011 | US20110071129 Spirodiamine-diaryl ketoxime derivative |
| 03/24/2011 | US20110071128 Novel imidazopyridines |
| 03/24/2011 | US20110071127 Compounds Which Modulate the CB2 Receptor |
| 03/24/2011 | US20110071126 Inhibitors of beta-secretase |
| 03/24/2011 | US20110071125 Substituted phenylamino-benzene derivatives useful for treating hyper-proliferative disorders and diseases associated with mitogen extracellular kinase activity |
| 03/24/2011 | US20110071124 Compounds that Inhibit Production of sAPPB and AB and Uses Thereof |
| 03/24/2011 | US20110071123 Noninvasive Method for Measuring Histamine From Skin as an Objective Measurement of Itch |
| 03/24/2011 | US20110071122 System for use by compounding pharmacists cists to produce hormone replacement medicine customized for each customer |
| 03/24/2011 | US20110071121 Diagnosis and/or prognosis of renal dysfunction |
| 03/24/2011 | US20110071120 Solid state forms of tapentadol salts |
| 03/24/2011 | US20110071119 Heat resistant delivery system |
| 03/24/2011 | US20110071118 Methods of Making Compositions Comprising Lecithin Oils and NSAIDS for Protecting the Gastointestinal Tract and Providing Enhanced Therapeuitc Activity |
| 03/24/2011 | US20110071117 Combinations of antioxidants and anti-inflammatory drugs in the treatment of inflammatory bowel disease |
| 03/24/2011 | US20110071116 Antimicrobial n-halogenated amino acid salts |
| 03/24/2011 | US20110071115 Pharmaceutically useful heterocycle-substituted lactams |
| 03/24/2011 | US20110071114 Compositions and methods for treating bacterial infections using ceftaroline |
| 03/24/2011 | US20110071113 Thiazole Derivatives and Use Thereof |
| 03/24/2011 | US20110071111 Cicletanine in combination with oral antidiabetic and/or blood lipid-lowering agents as a combination therapy for diabetes and metabolic syndrome |
| 03/24/2011 | US20110071110 Water Dispersible Policosanol Cyclodextrin Complex and Method of its Production |
| 03/24/2011 | US20110071109 Histone deacetylase inhibitors as therapeutic agents for lysosomal storage disorders |
| 03/24/2011 | US20110071108 Beta-Cyclodextrin Derivatives as Antibacterial Agents |
| 03/24/2011 | US20110071107 Uses of water-soluble cellulose derivatives for preventing or treating metabolic syndrome |
| 03/24/2011 | US20110071106 Glycosaminoglycan oral use and compositions |
| 03/24/2011 | US20110071105 Wound-healing pharmaceutical compositions in the form of a cream based on amino acids and sodium hyaluronate |
| 03/24/2011 | US20110071104 Methods for Treating Osteoarthritis |
| 03/24/2011 | US20110071103 Methods of treating hepatic encephalopathy |
| 03/24/2011 | US20110071102 Compositions and Methods to Treat Recurrent Medical Conditions |
| 03/24/2011 | US20110071101 Nucleoside Phosphonate Analogs |
| 03/24/2011 | US20110071100 Sulfobetaines for cancer, obesity, macular degeneration, neurodegenerative diseases |
| 03/24/2011 | US20110071099 Cationic Ceramides, And Analogs Thereof, And Their Use For Preventing Or Treating Cancer |
| 03/24/2011 | US20110071098 Flurbiprofen and muscle relaxant gel combinations thereof |
| 03/24/2011 | US20110071097 Cephalotaxus esters, methods of synthesis, and uses thereof |
| 03/24/2011 | US20110071096 Macrolides Having Antibiotic Activity |
| 03/24/2011 | US20110071095 Compositions and Methods for Increasing Telomerase Activity |
| 03/24/2011 | US20110071094 (d)-allose inducing programmed cell death in hormone refractory prostate cancer lines |